A new review found no clear benefits of melatonin for slowing MS, mixed results for symptom relief, and liver safety concerns ...

Blood levels of the protein NfL may help predict the risk of future disease activity and progression in people with MS, a ...

Thinning of a layer of nerve cells in the eye's retina was associated with slower cognitive processing in people with MS, per ...

Parental stress may help explain the link between disease burden and lower self-esteem in children and adolescents with POMS.

A study found generic versions of certain MS treatments were linked to more variable disease biomarker profiles than ...

The National MS Society launched a 'Campaign to End MS,' aiming to raise $1 billion for research and to improve access to ...

Reduced immune responses to the Epstein-Barr virus may help explain the efficacy of anti-CD20 therapy in people with MS, per ...

Higher physical activity was linked to lower MS risk mainly among people with low sun exposure in a Swedish study.

Adding probiotics to standard MS therapies may help to reduce fatigue, depression, and disability levels in RRMS, per data ...

Quantum is working with Thermo Fisher to prepare a Phase 2 trial of Lucid-MS in progressive MS after FDA clearance.

Higher OCB counts in newly diagnosed MS were linked to broader MRI lesion spread and poorer verbal learning and memory.

A personalized neuropsychological rehab program may help people with MS manage cognitive issues, according to a feasibility ...